glp 1 cardiovascular disease and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia 8 Benefits of GLP‑1's Beyond
Description
It works well as a refreshing breakfast or a small meal when appetite feels lower
Whats Not Normaland Needs Attention While rare, some symptoms warrant closer evaluation
(2023, August 3)
27,36 In a controlled study, 63 patients with type 2 diabetes and a lower-extremity ulcer were randomized to either saxagliptin 5 mg or placebo daily
